Your session is about to expire
← Back to Search
HEALTH-P2 Intervention for Preventing Obesity During and After Pregnancy (HEALTH-P2 Trial)
HEALTH-P2 Trial Summary
This trial is testing whether an evidence-based intervention can help prevent excessive weight gain during and after pregnancy, when delivered through a national home visiting organization. If successful, the intervention could have a significant impact on obesity and related chronic diseases.
HEALTH-P2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHEALTH-P2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HEALTH-P2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I speak English or Spanish.I cannot participate in a walking program.I am between 18 and 45 years old.You are currently pregnant.
- Group 1: HEALTH-P2
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available for this clinical study?
"Affirmative. According to information posted on clinicaltrials.gov, the trial is currently recruiting participants and was initially listed on February 3rd 2020 with its last update taking place on October 28th 2022. This research endeavour requires 784 patients across a single site."
How many individuals have signed up to partake in this experiment?
"Affirmative. According to clinicaltrials.gov, this clinical trial is actively seeking participants and has been since February 3rd 2020. The listing was last updated on October 28th 2022 and 784 people across a single site are required for enrolment purposes."
What potential risks do patients face when using HEALTH-P2?
"Although preliminary evidence exists of HEALTH-P2's safety, efficacy has yet to be substantiated. Therefore, our team at Power rated the drug a 2 on their 1-3 scale."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger